FDA Approves New U.S. Labeling For ISENTRESS

Merck , known as MSD outside the United States and Canada, have announced that the U.S. Food and Drug Administration has approved new labeling for ISENTRESS Film-coated Tablets, Merck's integrase inhibitor for the treatment of HIV-1 infection in adult patients as part of combination HIV therapy.

http://www.medicalnewstoday.com/releases/262796.php